• About
  • Meet The Team
  • Privacy Policy
Saturday, January 16, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

OncoCyte Corporation (OCX) Stock Is Popping Today. Here’s Why

by Hasnain R
October 15, 2020
in Featured, Mid Day Movers
Share on FacebookShare on Twitter

Shares of OncoCyte Corporation (AMEX: OCX) soared 19.86% after the company announced that it is scheduled to present data on DetermaRxTM by the International Association for the study of lung cancer. The company will present the data at IASLC 2020 North America Conference. DetermaRx is a treatment stratification test that spot stage I-IIA non-small cell lung cancer (NSCLC) patients at high risk of recurrence despite ostensibly curative surgery, who may benefit from the addition of chemotherapy.

This test is adopted by seventy different hospitals since its launch including National Cancer Institutes (NCI) and National Comprehensive Cancer Network (NCCN) cancer centers and is funded by Medicare. The company has provided the presentation highlights from the prospective study of 250 patients that received this test.

It has been revealed by the company that 94% of patients who chose adjuvant chemotherapy were cancer-free and those patients who avoid adjuvant chemotherapy had experienced cancer again. These patients have received the high-risk status from the DetermaRx test.

Additionally, this test is also useful as it informs patients whether they need chemotherapy or not and prevent them from dangerous chemotherapy. All the patients have received the low-risk status from the DetermaRx test. Only 5% of patients have got cancer again.

Oncotcyte Corporation (AMEX: OCX) shares were trading up 19.86% at $1.57 on Wednesday. Oncotcyte Corporation share price went from a low point around $1.15 to briefly over $3.51 in the past 52 weeks, though shares have since pulled back to $1.75. It has moved up 52-1.7% from its 52-weeks low and moved down -50.14% from its 52-weeks high. OCX market cap has remained high, hitting $117.69 million at the time of writing.

DetermaRx is useful as it provides the necessary information related to high-risk patients and informed them about adjuvant chemotherapy. It is important as a post-surgical treatment in patients diagnosed with NSCLC. The company revealed that if we combine the risk status provided by DetermaRx and EGFR mutation status it may help non-small cell lung cancer (NSCLC) patients. The result will be revealed at the KOL webinar on October 22nd at 11:00 am PT.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: AMEX: OCXchemotherapyIASLC 2020 North America ConferenceNational Cancer Institutes (NCI)NSCLCOCX stockOncoCyte Corporation

Related Posts

Top 15 Information Technology Stocks You Should Be Holding
Featured

Why Momo Inc (MOMO) Is Attracting Investors?

January 14, 2021
Telecom Stocks to Look Out for in 2021
Featured

Telecom Stocks to Look Out for in 2021

January 13, 2021
TG Therapeutics (NASDAQ: TGTX) Ublituximab Receives Fast Track Designation In US
Featured

Why T2 Biosystems Inc. (TTOO) is stock surging in the Pre-market hours today?

January 12, 2021
Top 20 Banking Industry Stocks For October 2020
Featured

Are These The Best Battery Stocks To Buy This Year

January 11, 2021
Blonder Tongue Receives U.S. Patent Grant For DMM Series Of Products
Featured

Can We Expect Growth From General Electric (GE) In 2021?

January 11, 2021
Beasley Broadcast Group (NASDAQ: BBGI) Announces Operating Results
Featured

Where The Li Auto (LI), XPeng (XPEV) Stocks Are Heading To

January 8, 2021
Next Post
GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020

Interpace Biosciences [IDXG] Rockets after Beating Complaint

Early Morning Vibes: The 4 Best Stocks To Buy Now

Blonder Tongue Receives U.S. Patent Grant For DMM Series Of Products
by Shan Zee
January 14, 2021
0

American stock markets ended trading largely in the green zone on January 13. The S&P 500 index improved to 3810...

Read more

Early Morning Vibes: Check Out These 4 hot Stocks Right Now

GILT Stock
by Shan Zee
January 12, 2021
0

On January 11, American stock markets closed in the red. The S & P500 index fell 0.66% to 3800 points,...

Read more

Early Morning Vibes: Watch These 4 Stocks Today

Beasley Broadcast Group (NASDAQ: BBGI) Announces Operating Results
by Shan Zee
January 13, 2021
0

The US stock indexes were traded in small ranges on January 12. The S&P 500 has risen symbolically by 0.04%...

Read more

Early Morning Vibes: 4 Stocks We Like for Friday

by Shan Zee
January 15, 2021
0

On January 14, the American stock indices closed in the red. The S&P 500 index dropped 0.38% to 3796 points,...

Read more

Early Morning Vibes: 4 Top Trending Stocks To Watch For Monday

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
by Shan Zee
January 11, 2021
0

Last week indices in the United States managed to set fresh records on the price boards. Interestingly, we saw Wall...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.